Latest therapeutics News | Page 2

Copper drug restores memory and clears toxic Alzheimer’s proteins
Open: CSIRO’s One Health program for Australian SMEs with early-stage health ideas
Kanvas Biosciences raises $48 million to advance microbiome cancer therapies
QIMR Berghofer and TFBS Bioscience sign MOU to advance cell and gene therapies
RNA Researcher Joins L’Oréal-UNESCO Mentoring Scheme
Research Project Promoting Patient-Specific Nucleic Acid Drug Development for Rare and Intractable Diseases (N-of-1+ Drug Development) Selected by AMED
New biotech partnership to deliver advances in biomedical technology
Nobel mini-symposium at KI on advances in antibody diversification and engineering
Nobel Mini-Symposium on Advances in Antibody Diversification and Engineering at Karolinska Institutet
Queensland Government puts new biomedical projects on the global map
HKUST Researchers Flip the CRISPR Script to Develop World’s First DNA-Guided Gene Editing Tool for Precise Infectious Disease Diagnosis and Advancing Antiviral Therapies
WHO Member States agree to extend negotiations on Pathogen Access and Benefit Sharing annex
Griffith and Thermo Fisher Sign MoU to Advance Innovation at GCHKP
Macquarie University hosts landmark RNA research and manufacturing facility
Study Finds Each Protein in the Epigenome Produces a Different Pattern of Gene Expression
Delivering oxygen through the intestine: enteral ventilation shows promise in human trials
Drug developer acquires potential cancer treatment discovered by QIMR Berghofer researcher
Human skin model to help treat skin stiffened by age and disease
Fish “Steals” Glowing Protein: Genome Sequencing Proves Unique Survival Strategy
How an Injectable Particle Could Make Surgery Safer for Infants
New Sensors Lower Cost Of Studying Genetic Disorders
WHO Member States agree to extend negotiations on key annex to the Pandemic Agreement
Pain neurons protect nerve health and offer new therapeutic targets
Cellular ‘atlas’ of prostate cancer opens new avenues for earlier detection
New medicine piggybacks onto fat absorption pathways to allow oral delivery and support clinical trial in major depressive disorder
AMA President’s update: scope of practice; medicinal cannabis, Ahpra news and more
Researchers use NMR, mathematical modelling and simulations to reveal how a tryptophan-rich allosteric communication network helps activate a major drug target receptor
HKUST Researchers Achieve Breakthrough in RNA Silencing Mechanism
Smart bandage could heal and monitor wounds at the same time
New smart bandage could heal and monitor wounds at the same time
Promobilia grant supports research into long-term pain relief
Federal government prescribing trial fails to put quality women’s healthcare first
Turning penicillin into a lethal force against bacteria again
Monash Researchers Awarded up to $22.4 Million AUD to Develop New Medicines for Restoring Lymphatic Pumping
Fat cells burn energy to make heat – making them the next frontier of weight loss therapies
Prior authorization bans for opioid treatment may not improve retention
$152 million to help bring medical innovations to market and increase consumer involvement in research
A promising potential therapeutic strategy for Rett syndrome
Monash University and Seaport Therapeutics Awarded up to $21 Million AUD from ARPA-H to Advance GlyphCeleTM, the First Oral Therapeutic Designed to…
Australian consortium to develop quantum biotechnology platform to transform Alzheimer’s treatment discovery
How Studying Yeast in the Gut Could Lead to New, Better Drugs
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
Exploring how the immune system detects drugs coated with ‘stealth’ polymers
Dogs With Cancer Could Leave Lasting Legacy
Nipah virus: What we know and how Australian researchers are responding
Two new partners of NextGenNK share news about NK cell-based immunotherapies
Monash study shows subcutaneous delivery with hyaluronidase may boost effectiveness of cancer immunotherapy
MPG Spin-off QLi5 receives Multi-million Euro Investment from Qurient Therapeutics